Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies

被引:0
|
作者
Rajnish Kumar
Priyanka Malla
Abhilasha Verma
Manoj Kumar
机构
[1] Panjab University,University Institute of Pharmaceutical Sciences
来源
关键词
5α-Reductase; Docking; Dihydrotestosterone; CoMFA; CoMSIA;
D O I
暂无
中图分类号
学科分类号
摘要
3D-QSAR CoMFA, CoMSIA and docking studies were performed on a set of 4-azasteroidal human steroid 5α-reductase inhibitors. The models developed using maximal common substructure-based alignment was found to be reliable and significant with good predictive r2 value. CoMSIA model developed using combination of steric, electrostatic, hydrophobic, hydrogen bond donor and hydrogen bond acceptor features has shown rcv2 = 0.564 with six optimum components, rncv2 = 0.945, F value = 101.196, rPred2 = 0.693 and SEE = 0.209. The contour plots obtained has shown a favourable effect of bulkier groups at C-17 position. Docking studies indicates the importance of bulkier groups at C-17 position for favourable activity. The study further helps in design of potent inhibitors of the enzyme.
引用
收藏
页码:4568 / 4580
页数:12
相关论文
共 50 条
  • [31] 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches
    Khanfar, Mohammad A.
    Youssef, Diaa T. A.
    El Sayed, Khalid A.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3662 - 3668
  • [32] 3D-QSAR Studies on DATAs and DAPYs for HIV-RT Inhibitors using CoMFA and CoMSIA Approaches
    Park, Hyung Yeon
    Ju, Sun Mi
    Lee, Do Young
    Zhang, Hui
    Kim, Chan Kyung
    [J]. QSAR & COMBINATORIAL SCIENCE, 2009, 28 (02): : 218 - 225
  • [33] 3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA
    Wang, Rong Wei
    Zhou, Lu
    Zuo, Zhili
    Ma, Xiang
    Yang, Min
    [J]. MOLECULAR SIMULATION, 2010, 36 (02) : 87 - 110
  • [34] 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors
    Murthy, VS
    Kulkarni, VM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (07) : 2267 - 2282
  • [35] The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA
    Choo, HYP
    Choi, S
    Jung, SH
    Koh, HY
    Pae, AN
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) : 4585 - 4589
  • [36] 3D-QSAR COMFA AND COMSIA ON PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORS
    Shukla, Vipasha
    Gupta, Swati
    Saxena, Anil K.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S147 - S147
  • [37] QSAR studies of histone deacetylase (HDAC) inhibitors by CoMFA, CoMSIA, and molecular docking
    Zhang, Lei
    Fang, Hao
    Zhu, Huawei
    Wang, Qiang
    Xu, Wenfang
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2009, 3 (02): : 41 - 48
  • [38] QSAR studies on diclofenac analogues as potent cyclooxygenase inhibitors using CoMFA and CoMSIA
    Arvind, K.
    Solomon, K. Anand
    Rajan, S. S.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (04) : 1789 - 1796
  • [39] 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors
    Dessalew, Nigus
    Singh, Sanjeev Kumar
    [J]. MEDICINAL CHEMISTRY, 2008, 4 (04) : 313 - 321
  • [40] QSAR studies on diclofenac analogues as potent cyclooxygenase inhibitors using CoMFA and CoMSIA
    K. Arvind
    K. Anand Solomon
    S. S. Rajan
    [J]. Medicinal Chemistry Research, 2014, 23 : 1789 - 1796